“Today, according to the Ministry of Foreign Affairs of Russia, 27 countries of the world expressed a desire to purchase a vaccine against a new coronavirus infection, a Russian vaccine,” Golikova said.

Earlier, the Ministry of Health of Russia issued the N.N. Gamaleya permission to conduct post-marketing studies of the COVID-19 vaccine.

The director of the Gamaleya Center, Alexander Gintsburg, also noted that the civil circulation of the COVID-19 vaccine could begin a month after the start of the third, post-registration stage of drug research.